Gerstein Fisher’s Pfizer PFE Stock Holding History

Gerstein Fisher’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$2.56M	Buy	79,710 +10,953	+16%	+$366K	0.32%	57
2016 Q2	$2.3M	Buy	68,757 +7,863	+13%	+$251K	0.3%	63
2016 Q1	$1.71M	Buy	60,894 +863	+1%	+$24.7K	0.23%	89
2015 Q4	$1.84M	Sell	60,031 -5,518	-8%	-$174K	0.26%	82
2015 Q3	$1.95M	Buy	65,549 +2,088	+3%	+$66.9K	0.29%	64
2015 Q2	$2.02M	Sell	63,461 -366	-0.6%	-$11.9K	0.33%	62
2015 Q1	$2.11M	Sell	63,827 -1,544	-2%	-$49.1K	0.35%	58
2014 Q4	$1.93M	Sell	65,371 -3,042	-4%	-$87.2K	0.31%	66
2014 Q3	$1.92M	Buy	68,413 +7,750	+13%	+$218K	0.34%	56
2014 Q2	$1.71M	Buy	60,663 +1,739	+3%	+$49.6K	0.32%	56
2014 Q1	$1.8M	Sell	58,924 -75,379	-56%	-$2.25M	0.36%	54
2013 Q4	$3.9M	Buy	134,303 +73,081	+119%	+$2.13M	0.15%	157
2013 Q3	$1.67M	Buy	61,222 +1,808	+3%	+$49.2K	0.36%	43
2013 Q2	$1.58M	Buy	+59,414	New	+$1.64M	0.38%	38

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Gerstein Fisher's PFE Position: Q3 2016 in Review

Gerstein Fisher increased its Pfizer (PFE) stake by 16% in Q3 2016, buying an estimated $366K and bringing the position to 79,710 shares worth $2.56M. The position accounts for 0.32% of the portfolio, ranked #57.

Gerstein Fisher first reported a position in PFE in Q2 2013 and has held it in 14 quarters since. The position peaked at $3.9M in Q4 2013. 1,963 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

Gerstein Fisher held 79,710 shares of Pfizer worth $2.56M as of Q3 2016.
Gerstein Fisher bought 10,953 Pfizer shares in Q3 2016, an estimated $366K.
Pfizer made up 0.32% of Gerstein Fisher's portfolio in Q3 2016, its #57 holding.
Gerstein Fisher first reported a position in Pfizer in Q2 2013 and has held it in 14 quarters since.
Gerstein Fisher's Pfizer position peaked at $3.9M in Q4 2013.
1,963 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Gerstein Fisher's 13F filing for Q3 2016, filed 15 Nov 2016.